Table 2 Noncompliance rates in patient subgroups
From: Utilization of radiation therapy and predictors of noncompliance among Syrian refugees in Turkey
| Characteristic | Noncompliance rate, n (%) | P |
|---|---|---|
| Sex | 0.903 | |
| Male | 98/479 (21) | |
| Female | 107/531 (20) | |
| History of Smoking | 73/364 (20) | 0.886 |
| Family history of cancer | 10/85 (12) | 0.041 |
| Residence | <.001 | |
| Refugee Camp | 146/442 (33) | |
| House | 59/568 (10) | |
| Diagnosis | 0.141 | |
| Breast cancer | 65/303 (22) | |
| Lung cancer | 24/137 (18) | |
| CNS cancer | 25/128 (20) | |
| Head and neck cancer | 25/110 (23) | |
| GI cancer | 15/101 (15) | |
| Prostate cancer | 16/69 (23) | |
| Gyn cancer | 7/64 (11) | |
| Others | 28/98 (28) | |
| Stage | 0.192 | |
| I-II | 46/202 (23) | |
| III-IV | 128/687 (19) | |
| Concurrent chemoradiotherapy | 62/264 (24) | 0.134 |
| Grade 3–4 acute toxicity | 20/139 (14) | 0.062 |